Regulation of an Open Access Essential Facility
Bibliographic Data
| ID | 9725174 |
|---|---|
| Authors | Axel Gautier (0000-0001-7700-3814, UCB Pharma (Belgium)), MANIPUSHPAK MITRA (0000-0003-2081-6173, Indian Statistical Institute) |
| Year | 2008 |
| Volume | 75 |
| Issue | 300 |
| Pages | 662-682 |
| Publication date | 2008-11-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Economica (JOURNAL) |
| Journal identifiers | ISSN: 0013-0427 • E-ISSN: 1468-0335 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/j.1468-0335.2007.00638.x |
| OpenAlex | W3119151291 |
| Language | EN |
| Citations received | 2 |
| References cited | 14 |
A vertically integrated firm owns an essential input and operates on the downstream market. There is a potential entrant in the downstream market. Both firms use the same essential input. The regulator's objectives are (i) to ensure financing of the essential input and (ii) to generate competition in the downstream market. The regulatory mechanism grants non‐discriminatory access of the essential facility to the entrant provided it pays a two‐part tariff to the incumbent. The optimal mechanism generates inefficient entry. The inefficient entry captures the trade‐off between market efficiency and infrastructure financing resulting from incomplete information and non‐discriminatory access
Business · Competition (biology) · Competitor analysis · Downstream (manufacturing) · Economics · Industrial organization · Market access · Market economy · Market mechanism · Market structure · Mechanism (biology) · Vertical Integration · Auction Theory and Applications · Consumer Market Behavior and Pricing · Marketing · Merger and Competition Analysis
| Unique citing works | 2 |
|---|---|
| Citations per year | 0.13 |
| Citation span | 2010 - 2014 (5) |
| Citation velocity | historical |
| Highly cited | No |